Quintiles IMS Holdings Inc  

(Public, NYSE:Q)   Watch this stock  
Find more results for Q
+0.36 (0.43%)
Real-time:   3:39PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 83.24 - 84.31
52 week 61.21 - 85.59
Open 83.98
Vol / Avg. 307,412.00/1.20M
Mkt cap 18.58B
P/E 76.30
Div/yield     -
EPS 1.10
Shares 220.04M
Beta 0.64
Inst. own 94%

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 3.32% 1.95%
Operating margin 7.11% 8.88%
EBITD margin - 16.24%
Return on average assets 1.46% 1.07%
Return on average equity 3.66% 2.85%
Employees 50,000 -
CDP Score - C


4820 Emperor Blvd
DURHAM, NC 27703-8426
United States - Map
+1-919-9982000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Quintiles IMS Holdings, Inc., formerly Quintiles Transnational Holdings Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.

Officers and directors

Ari Bousbib Chairman of the Board, President, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Thomas H. Pike Vice Chairman of the Board; President, Research & Development Solutions
Bio & Compensation  - Reuters
Michael R. McDonnell Chief Financial Officer, Executive Vice President
Age: 53
Bio & Compensation  - Reuters
Kevin C. Knightly President - Information and Technology Solutions
Age: 55
Bio & Compensation  - Reuters
James H. Erlinger III Executive Vice President, General Counsel, Secretary
Age: 57
Bio & Compensation  - Reuters
John G. Danhakl Director
Age: 60
Bio & Compensation  - Reuters
James A. Fasano Director
Age: 47
Bio & Compensation  - Reuters
Dennis B. Gillings Ph.D. Director
Age: 67
Bio & Compensation  - Reuters
Ronald A. Rittenmeyer Director
Age: 69
Bio & Compensation  - Reuters
Todd B. Sisitsky Director
Age: 45
Bio & Compensation  - Reuters